Nature Genetics· 2026Q1
Type 1 interferon perturbates clonal competition by reshaping human blood development
- 0citations
- Q1SCImago
- 2026year
Short summary
Interferon-α (IFNα) treatment normalizes blood counts in myeloproliferative neoplasms by promoting lymphoid differentiation and balancing the typical myeloid bias, while also revealing that mutated stem cells resist differentiating into inflammatory myeloid progenitors.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Genetics
GeneticsMedicine